drugset / Trial / NCT00490269

Ph1 Marinol Interaction Study - Part 2 - 1

NCT00490269

Phase 1 Completed 12 enrolled National Institute on Drug Abuse (NIDA)
RandomizedParallel-groupQuadruple-blind

Summary

This study will examine the effects of oral dronabinol tetrahydrocannabinol (THC) on withdrawal symptoms in marijuana dependent volunteers, and evaluate the safety, pharmacokinetics (PK), and cardiovascular effects of the combination of oral dronabinol and smoked marijuana to determine if there are potential significant drug interactions before conducting outpatient studies.

Timeline

Start
2006-10
Primary completion
2007-12
Completion
2007-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dronabinol Other / unclassified Oral

Indications